Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Bayer CropScience has informed that in the wake of the global COVID-19 pandemic, and in compliance with the directives of Government of India/ State Governments, the Company has adopted several measures to ensure the safety and wellbeing of all its employees, including providing IT infrastructure and connectivity to enable them to work from home. Across the office and site locations, the Company has implemented heightened hygiene, health and sanitation measures and is promoting social distancing. In view of the 21-day nationwide lockdown announced by the Government of India (GOI) with effect from March 25, 2020, to control the spread of COVID-19, the Company’s operations related to manufacturing, supply chain, warehouses, and offices are disrupted (except for certain essential services). The impact of COVID-19 on the Company’s operations cannot be fully ascertained at this point.

The above information is a part of company’s filings submitted to BSE.

Related Bayer CropScience Ltd. Links:

Bayer CropScience Share Price

5144.15 46.60 (0.91%) Feb 25, 18:59
1 Year Price Chart
Peers
Company Name CMP
UPL 592.45
BASF India 2006.70
Bayer CropScience 5144.15
PI Industries 2217.45
Rallis India 261.95
View more..
Sensex vs Bayer CropScience
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback